NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes

Rosa Lombardi; Lorena Airaghi; Giovanni Targher; Gaetano Serviddio; Gabriele Maffi; Alessandro Mantovani; Claudio Maffeis; Antonio Colecchia; Rosanna Villani; Luca Rinaldi; Emanuela Orsi; Giuseppina Pisano; Luigi Elio Adinolfi; Silvia Fargion; Anna Ludovica Fracanzani

doi:10.1016/j.jdiacomp.2020.107684

NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes

Rosa Lombardi, Lorena Airaghi, Giovanni Targher, Gaetano Serviddio, Gabriele Maffi, Alessandro Mantovani, Claudio Maffeis, Antonio Colecchia, Rosanna Villani, Luca Rinaldi, Emanuela Orsi, Giuseppina Pisano, Luigi Elio Adinolfi, Silvia Fargion, Anna Ludovica Fracanzani

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Article

Abstract

We demonstrate in 351 diabetic patients with steatosis that NAFLD fibrosis score (NFS), a rapid and affordable score to diagnose hepatic fibrosis, identifies patients at higher risk of advanced fibrosis and vascular diabetic complications (especially peripheral neuropathy), pointing NFS as a first-line vascular and hepatic screening in diabetic patients.

Original language	English
Article number	107684
Journal	Journal of Diabetes and its Complications
Volume	34
Issue number	11
DOIs	https://doi.org/10.1016/j.jdiacomp.2020.107684
Publication status	Published - 2020

Keywords

Diabetic neuropathy
Microvascular complications
NAFLD
Non-invasive diagnosis
Stroke
Type 2 diabetes screening

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology

Access to Document

10.1016/j.jdiacomp.2020.107684

Fingerprint Dive into the research topics of 'NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes'. Together they form a unique fingerprint.

Cite this

Lombardi, R., Airaghi, L., Targher, G., Serviddio, G., Maffi, G., Mantovani, A., Maffeis, C., Colecchia, A., Villani, R., Rinaldi, L., Orsi, E., Pisano, G., Adinolfi, L. E., Fargion, S., & Fracanzani, A. L. (2020). NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes. Journal of Diabetes and its Complications, 34(11), [107684]. https://doi.org/10.1016/j.jdiacomp.2020.107684

NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes. / Lombardi, Rosa; Airaghi, Lorena; Targher, Giovanni; Serviddio, Gaetano; Maffi, Gabriele; Mantovani, Alessandro; Maffeis, Claudio; Colecchia, Antonio; Villani, Rosanna; Rinaldi, Luca; Orsi, Emanuela ; Pisano, Giuseppina; Adinolfi, Luigi Elio; Fargion, Silvia; Fracanzani, Anna Ludovica.

In: Journal of Diabetes and its Complications, Vol. 34, No. 11, 107684, 2020.

Research output: Contribution to journal › Article

Lombardi, R, Airaghi, L, Targher, G, Serviddio, G, Maffi, G, Mantovani, A, Maffeis, C, Colecchia, A, Villani, R, Rinaldi, L, Orsi, E , Pisano, G, Adinolfi, LE, Fargion, S & Fracanzani, AL 2020, 'NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes', Journal of Diabetes and its Complications, vol. 34, no. 11, 107684. https://doi.org/10.1016/j.jdiacomp.2020.107684

Lombardi, Rosa ; Airaghi, Lorena ; Targher, Giovanni ; Serviddio, Gaetano ; Maffi, Gabriele ; Mantovani, Alessandro ; Maffeis, Claudio ; Colecchia, Antonio ; Villani, Rosanna ; Rinaldi, Luca ; Orsi, Emanuela ; Pisano, Giuseppina ; Adinolfi, Luigi Elio ; Fargion, Silvia ; Fracanzani, Anna Ludovica. / NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes. In: Journal of Diabetes and its Complications. 2020 ; Vol. 34, No. 11.

@article{92cbb544d52846f5a651d428bca33af2,

title = "NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes",

abstract = "We demonstrate in 351 diabetic patients with steatosis that NAFLD fibrosis score (NFS), a rapid and affordable score to diagnose hepatic fibrosis, identifies patients at higher risk of advanced fibrosis and vascular diabetic complications (especially peripheral neuropathy), pointing NFS as a first-line vascular and hepatic screening in diabetic patients.",

keywords = "Diabetic neuropathy, Microvascular complications, NAFLD, Non-invasive diagnosis, Stroke, Type 2 diabetes screening",

author = "Rosa Lombardi and Lorena Airaghi and Giovanni Targher and Gaetano Serviddio and Gabriele Maffi and Alessandro Mantovani and Claudio Maffeis and Antonio Colecchia and Rosanna Villani and Luca Rinaldi and Emanuela Orsi and Giuseppina Pisano and Adinolfi, {Luigi Elio} and Silvia Fargion and Fracanzani, {Anna Ludovica}",

year = "2020",

doi = "10.1016/j.jdiacomp.2020.107684",

language = "English",

volume = "34",

journal = "Journal of Diabetes and its Complications",

issn = "1056-8727",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes

AU - Lombardi, Rosa

AU - Airaghi, Lorena

AU - Targher, Giovanni

AU - Serviddio, Gaetano

AU - Maffi, Gabriele

AU - Mantovani, Alessandro

AU - Maffeis, Claudio

AU - Colecchia, Antonio

AU - Villani, Rosanna

AU - Rinaldi, Luca

AU - Orsi, Emanuela

AU - Pisano, Giuseppina

AU - Adinolfi, Luigi Elio

AU - Fargion, Silvia

AU - Fracanzani, Anna Ludovica

PY - 2020

Y1 - 2020

N2 - We demonstrate in 351 diabetic patients with steatosis that NAFLD fibrosis score (NFS), a rapid and affordable score to diagnose hepatic fibrosis, identifies patients at higher risk of advanced fibrosis and vascular diabetic complications (especially peripheral neuropathy), pointing NFS as a first-line vascular and hepatic screening in diabetic patients.

AB - We demonstrate in 351 diabetic patients with steatosis that NAFLD fibrosis score (NFS), a rapid and affordable score to diagnose hepatic fibrosis, identifies patients at higher risk of advanced fibrosis and vascular diabetic complications (especially peripheral neuropathy), pointing NFS as a first-line vascular and hepatic screening in diabetic patients.

KW - Diabetic neuropathy

KW - Microvascular complications

KW - NAFLD

KW - Non-invasive diagnosis

KW - Stroke

KW - Type 2 diabetes screening

UR - http://www.scopus.com/inward/record.url?scp=85089656001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85089656001&partnerID=8YFLogxK

U2 - 10.1016/j.jdiacomp.2020.107684

DO - 10.1016/j.jdiacomp.2020.107684

M3 - Article

AN - SCOPUS:85089656001

VL - 34

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 11

M1 - 107684

ER -